Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 29;16(6):e63464.
doi: 10.7759/cureus.63464. eCollection 2024 Jun.

Exploring the Link Between Metabolic Syndrome and Cellulite

Nikos Adamidis  1 , Petros Papalexis  2 , Sotirios Adamidis  3
Affiliations
Review

Exploring the Link Between Metabolic Syndrome and Cellulite

Nikos Adamidis et al. Cureus. .

Abstract

Metabolic syndrome (MetS) encompasses a cluster of metabolic abnormalities, including insulin resistance, hypertension, abdominal obesity, and dyslipidemia, increasing cardiovascular disease and type 2 diabetes risks. Cellulite, a cosmetic condition marked by dimpled skin, predominantly affects women and shares risk factors with MetS, such as obesity and hormonal imbalances. This review examines the potential link between MetS and cellulite, focusing on shared pathophysiological pathways and implications for clinical practice and future research. Common factors such as inflammation, hormonal changes, and adipose tissue dysfunction are explored. The review highlights the importance of longitudinal studies to track cellulite progression in MetS patients, biomarker identification for early detection, intervention trials to assess therapeutic efficacy, mechanistic studies to elucidate underlying pathways and the impact of comorbidities on cellulite development. Understanding these relationships can enhance prevention, diagnosis, and treatment strategies for both MetS and cellulite, addressing significant public health and cosmetic concerns.

Keywords: adipose tissue dysfunction; cellulite; hormonal impalance; inflammation; metabolic syndrome.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

References

    1. Metabolic syndrome pandemic. Grundy SM. Arterioscler Thromb Vasc Biol. 2008;28:629–636. - PubMed
    1. Cellulite: a review. Rossi AB, Vergnanini AL. J Eur Acad Dermatol Venereol. 2000;14:251–262. - PubMed
    1. Metabolic syndrome — a new world-wide definition. A consensus statement from the International Diabetes Federation. Alberti KG, Zimmet P, Shaw J. Diabet Med. 2006;23:469–480. - PubMed
    1. Treatment for cellulite. Sadick N. Int J Womens Dermatol. 2019;5:68–72. - PMC - PubMed
    1. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Ford ES, Giles WH, Dietz WH. JAMA. 2002;287:356–359. - PubMed

LinkOut - more resources